Outcome base rates
What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.
No merits decisions in the current scope.
PI grant rate
—
PI grant rate (conservative)
—
Infringement rate
—
Revocation rate
—
0 revoked / partially · 0 maintained / amended
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
50% 1 / 2
Outcomes by category (detailed)
Stacked breakdown using sharper outcome enums — revocation cases split into revoked_full / revoked_partial / maintained_as_*, etc.
Settlement timing
When settled or withdrawn cases actually closed — relative to procedural milestones.
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
- Revocation24
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
- Munich LD24 casesPI grant rate: —Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
- 2025-12-19UPC_CFI_681/2024Munich LDNot infringedThe Munich Local Division dismissed both the infringement action (UPC_CFI_437/2024) brought by GXD-Bio Corporation and the counterclaim for revocation (UPC_CFI_681/2024) brought by the Myriad defendants, concerning EP 3 346 403 (a patent on data processing/gene expression analysis for identifying endogenous reference genes). The Court found no infringement because the accused products (Myriad test kits) did not use the claimed three-step normalization method — the products used a single-step average normalization that differed from the patented calculation method. The counterclaim for revocation was also dismissed, so the patent was maintained. Each party bears its own costs, with costs capped at EUR 600,000 total.
- 2025-10-16UPC_CFI_564/2024Munich LDWithdrawnThe Munich Local Division permitted the withdrawal of the defendants' counterclaim for revocation of EP 2 387 547 under R. 265.1 RoP, after the main infringement/revocation proceedings had already been decided on 22 August 2025 and within the appeal period, with no costs order by agreement of the parties.